Internal Medicine, Hematology & Oncology · Portland, OR
NPI
1790934149
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3600 N Interstate Ave
Portland, OR, 97227
Phone (503) 331-6500
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
511 services
Medicare patients, 2024
12
Average age 67
Drug cost, 2024
$6.7M
2,175 prescriptions
Company payments, 2025
$0
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug Abdul Hai Mansoor prescribed most often to Medicare patients was Dexamethasone, with 261 prescriptions and refills. In total Abdul Hai Mansoor wrote 2,175 Medicare prescriptions that cost $6.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-31.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Dexamethasone Generic | 261 | 278 | 54 | $2,967 |
| Lenalidomide Generic | 193 | 193 | 27 | $2.4M |
| Acyclovir Generic | 182 | 454 | 58 | $4,894 |
| Hydroxyurea Generic | 155 | 360 | 39 | $4,421 |
| Ondansetron Hcl Generic | 87 | 87 | 29 | $664 |
| Oxycodone Hcl Generic | 74 | 74 | 45 | $854 |
| Jakafi Ruxolitinib Phosphate | 74 | 74 | Under 11 | $628K |
| Potassium Chloride Generic | 73 | 123 | 27 | $1,602 |
| Prednisone Generic | 60 | 76 | 22 | $534 |
| Brukinsa Zanubrutinib | 59 | 59 | Under 11 | $777K |
| Lorazepam Generic | 58 | 58 | 41 | $326 |
| Amoxicillin Generic | 57 | 59 | 14 | $342 |
| Pomalyst Pomalidomide | 55 | 55 | 11 | $1.4M |
| Imatinib Mesylate Generic | 47 | 83 | Under 11 | $4,487 |
| Prochlorperazine Maleate Generic | 43 | 43 | 21 | $566 |
Brand drugs: 480 claims; generic drugs: 1,695 claims; opioid claims: 95.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdul Hai Mansoor $0 (- in general payments such as food, travel and fees) from 5 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.